Peptide Lot Traceability: COA and Label Checklist

Traceability is a chain, not a single lot number

A lot number printed on a vial is useful only when records connect it to the material tested and supplied. Map the chain from quotation and purchase order through production or filling, analytical sample, COA, finished label, packing list, shipment and receiving entry. Each transition should preserve identity or document a controlled relationship between identifiers. Buyers should not assume that similar lot codes refer to the same batch. Ask the supplier to explain its identifier structure and how repacking or subdivision is recorded.

Reconcile identity across commercial records

The product name, strength or unit content, physical form and lot should agree across the approved quotation, invoice, packing list and labels. Abbreviations must not introduce ambiguity between related peptides. When a commercial document uses a shortened name, retain a cross-reference to the approved specification. Check quantity and unit configuration as well as wording: ten cartons of ten vials is not the same receiving unit as one bulk container. Resolve discrepancies before shipment whenever possible, and record approved corrections rather than replacing files without an audit trail.

Connect the COA to supporting data

A batch-specific COA should identify the material and lot, list tests, specifications or acceptance criteria, report results and show issue or approval information. Where chromatograms or spectra are provided, their sample reference should connect to the COA lot. Investigate generic file names, missing sample identifiers or test dates that predate the stated batch without explanation. A COA summarizes evidence; it should not claim attributes that were not tested. Buyers should preserve the original issued file and any revised version with the reason for revision.

Handle parent lots, fill lots and packaging batches

Wholesale supply may involve a parent bulk lot followed by subdivision, filling or private-label packaging. The finished unit can therefore carry a secondary production or packaging identifier. Require a documented genealogy that relates these identifiers and records quantities consumed, released and rejected. If multiple strengths are filled from one parent lot, ensure the packaging and reconciliation records prevent mix-ups. If multiple parent lots are combined, the practice and its effect on testing must be disclosed and accepted under the buyer's specification.

Perform a receiving traceability check

At receipt, inspect outer cartons and a risk-based sample of units. Record the visible product identity, lot, unit content, quantity and package condition, then compare them with the packing list and approved records. Quarantine unexplained mismatches until quality review is complete. Photographs can support the receiving record but do not replace documented checks. Link internal inventory or aliquot identifiers back to the supplier lot, and preserve that link when material moves between storage locations or projects.

Audit corrections and document retention

Traceability systems must show what changed, who approved it and why. A corrected COA or label should use revision control and should not erase the previous issued version from the buyer's file. Agree retention periods that fit the research program and commercial obligations. Periodically retrieve a lot record from inventory and follow it backward to analytical evidence and forward to receiving disposition. A successful mock trace demonstrates that the process works beyond the moment of purchase.

Quality Control: make evidence part of the purchase specification

Quality review should begin before the purchase order. Define which attributes require testing, the acceptance criteria, the method expected and the records required for release. HPLC commonly supports chromatographic purity and mass spectrometry can support identity, but every result must be interpreted within method scope. Confirm that sample identifiers connect supporting data to the offered lot. Review the Pure Peptides Core quality-control framework and document exceptions before shipment. A supplier's general quality statement does not replace evidence for the actual batch.

Documentation: create a pre-shipment review gate

List required records in the RFQ and purchase order. Depending on the material and transaction, the set may include a batch-specific COA, analytical attachments, SDS, specification, supported storage statement, label proof, packing list and commercial shipment documents. Reconcile identity, lot, quantity and revision status across files. Use our COA and SDS documentation guide to structure the review. The importer remains responsible for current local requirements, and no supplier should promise universal customs clearance.

Related products and same-category reading

For availability and specification discussion, review Documentation Support. Continue with these related manufacturing & quality control resources:

• COA and SDS Import Documents
• HPLC and MS Testing

Frequently asked questions